Mechanism-based inactivation of CYP2B1 and its F-helix mutant by two tert-butyl acetylenic compounds: covalent modification of prosthetic heme versus apoprotein

J Pharmacol Exp Ther. 2009 Nov;331(2):392-403. doi: 10.1124/jpet.109.158782. Epub 2009 Aug 21.

Abstract

The mechanism-based inactivation of cytochrome CYP2B1 [wild type (WT)] and its Thr205 to Ala mutant (T205A) by tert-butylphenylacetylene (BPA) and tert-butyl 1-methyl-2-propynyl ether (BMP) in the reconstituted system was investigated. The inactivation of WT by BPA exhibited a k(inact)/K(I) value of 1343 min(-1)mM(-1) and a partition ratio of 1. The inactivation of WT by BMP exhibited a k(inact)/K(I) value of 33 min(-1)mM(-1) and a partition ratio of 10. Liquid chromatography/tandem mass spectrometry analysis (LC/MS/MS) of the WT revealed 1) inactivation by BPA resulted in the formation of a protein adduct with a mass increase equivalent to the mass of BPA plus one oxygen atom, and 2) inactivation by BMP resulted in the formation of multiple heme adducts that all exhibited a mass increase equivalent to BMP plus one oxygen atom. LC/MS/MS analysis indicated the formation of glutathione (GSH) conjugates by the reaction of GSH with the ethynyl moiety of BMP or BPA with the oxygen being added to the internal or terminal carbon. For the inactivation of T205A by BPA and BMP, the k(inact)/K(I) values were suppressed by 100- and 4-fold, respectively, and the partition ratios were increased 9- and 3.5-fold, respectively. Only one major heme adduct was detected following the inactivation of the T205A by BMP. These results show that the Thr205 in the F-helix plays an important role in the efficiency of the mechanism-based inactivation of CYP2B1 by BPA and BMP. Homology modeling and substrate docking studies were presented to facilitate the interpretation of the experimental results.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acetylene / analogs & derivatives*
  • Acetylene / pharmacology
  • Alkynes / pharmacology*
  • Amino Acid Substitution
  • Apoproteins / chemistry
  • Apoproteins / drug effects
  • Apoproteins / metabolism*
  • Catalytic Domain / drug effects
  • Chromatography, High Pressure Liquid
  • Cytochrome P-450 CYP2B1 / antagonists & inhibitors*
  • Cytochrome P-450 CYP2B1 / chemistry
  • Cytochrome P-450 CYP2B1 / genetics*
  • Enzyme Inhibitors / pharmacology*
  • Ethers / pharmacology*
  • Glutathione / metabolism
  • Heme / chemistry
  • Heme / metabolism*
  • Humans
  • Kinetics
  • Mass Spectrometry
  • Models, Molecular
  • Mutation / drug effects*
  • Oxygen / chemistry
  • Protein Conformation / drug effects
  • Solubility
  • Spectrometry, Mass, Electrospray Ionization
  • Tandem Mass Spectrometry

Substances

  • 4-tert-butylphenylacetylene
  • Alkynes
  • Apoproteins
  • Enzyme Inhibitors
  • Ethers
  • tert-butyl 1-methyl-2-propynyl ether
  • Heme
  • Cytochrome P-450 CYP2B1
  • Glutathione
  • Acetylene
  • Oxygen